CUFinder

Amit Rupani

Amit Rupani

University of Michigan

H-index: 5

North America-United States

Contact Amit Rupani

About Amit Rupani

Amit Rupani, With an exceptional h-index of 5 and a recent h-index of 5 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Genomics and Bioinformatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC).

VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

935 VISTA regulates the differentiation of myeloid-derived suppressor cells by STAT3-dependent modulation of arginase-1 and iNOS expression and mitochondrial function

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies

Amit Rupani Information

University

Position

___

Citations(all)

123

Citations(since 2020)

99

Cited By

59

hIndex(all)

5

hIndex(since 2020)

5

i10Index(all)

3

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

Amit Rupani Skills & Research Interests

Genomics and Bioinformatics

Top articles of Amit Rupani

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research

2024/1/5

Nickolas Stabellini
Nickolas Stabellini

H-Index: 1

Pingfu Fu
Pingfu Fu

H-Index: 35

Amit Rupani
Amit Rupani

H-Index: 3

Topological heterogeneity of genomic and immunologic effects from combination immunotherapy treatment in the neoadjuvant setting for renal cell carcinoma (RCC).

2024/2/1

Amit Rupani
Amit Rupani

H-Index: 3

Vladimir Makarov
Vladimir Makarov

H-Index: 35

Steven Campbell
Steven Campbell

H-Index: 1

VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms

Cell reports

2024/1/23

Amin Zakeri
Amin Zakeri

H-Index: 6

Juan Dong
Juan Dong

H-Index: 17

Amit Rupani
Amit Rupani

H-Index: 3

Stanley Ching-Cheng Huang
Stanley Ching-Cheng Huang

H-Index: 26

Timothy Chan
Timothy Chan

H-Index: 24

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

OncoImmunology

2023/12/31

Amit Rupani
Amit Rupani

H-Index: 3

Vladimir Makarov
Vladimir Makarov

H-Index: 35

935 VISTA regulates the differentiation of myeloid-derived suppressor cells by STAT3-dependent modulation of arginase-1 and iNOS expression and mitochondrial function

2023/11/1

Amin Zakeri
Amin Zakeri

H-Index: 6

Juan Dong
Juan Dong

H-Index: 17

Amit Rupani
Amit Rupani

H-Index: 3

Abhishek Chakraborty
Abhishek Chakraborty

H-Index: 10

Stanley Huang
Stanley Huang

H-Index: 6

Timothy Chan
Timothy Chan

H-Index: 24

Li Wang
Li Wang

H-Index: 0

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings

Med

2021/7/9

Baris Akinci
Baris Akinci

H-Index: 17

Diana Rus
Diana Rus

H-Index: 11

The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies

PloS one

2020/10/7

Amit Rupani
Amit Rupani

H-Index: 3

Analisa Difeo
Analisa Difeo

H-Index: 26

Goutham Narla
Goutham Narla

H-Index: 31

See List of Professors in Amit Rupani University(University of Michigan)